KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Charles River Laboratories International (CRL) EPS (Weighted Average and Diluted) (2016 - 2025)

Historic EPS (Weighted Average and Diluted) for Charles River Laboratories International (CRL) over the last 17 years, with Q3 2025 value amounting to $1.1.

  • Charles River Laboratories International's EPS (Weighted Average and Diluted) fell 1729.32% to $1.1 in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.51, marking a year-over-year decrease of 11885.14%. This contributed to the annual value of $0.2 for FY2024, which is 9783.68% down from last year.
  • According to the latest figures from Q3 2025, Charles River Laboratories International's EPS (Weighted Average and Diluted) is $1.1, which was down 1729.32% from $1.06 recorded in Q2 2025.
  • Charles River Laboratories International's EPS (Weighted Average and Diluted)'s 5-year high stood at $3.65 during Q4 2022, with a 5-year trough of -$4.18 in Q4 2024.
  • Moreover, its 5-year median value for EPS (Weighted Average and Diluted) was $1.74 (2024), whereas its average is $1.53.
  • As far as peak fluctuations go, Charles River Laboratories International's EPS (Weighted Average and Diluted) skyrocketed by 5083.33% in 2022, and later tumbled by 21477.87% in 2024.
  • Over the past 5 years, Charles River Laboratories International's EPS (Weighted Average and Diluted) (Quarter) stood at $2.67 in 2021, then surged by 36.7% to $3.65 in 2022, then fell by 0.27% to $3.64 in 2023, then plummeted by 214.78% to -$4.18 in 2024, then soared by 126.33% to $1.1 in 2025.
  • Its EPS (Weighted Average and Diluted) was $1.1 in Q3 2025, compared to $1.06 in Q2 2025 and $0.5 in Q1 2025.